Tetramer/PE – HLA-A*02:01 IGRP (228-236) (LNIDLLWSV)
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Target | Diabetes |
|---|---|
| Product Type | Tetramer |
| Application | FCM |
| Conjugate | PE |
| Class | Class I |
| Species Reactivity | Human |
| Allele | HLA-A*02:01 |
| Peptide Sequence | LNIDLLWSV |
| Research Area | Immunology, Immune Monitoring |
| Protocols | FCM |
| Specificity | IGRP |
| Storage Temperature | 4°C |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
Related Products
Related Content
